Todd Christopher Longsworth, General Counsel at NovoCure Ltd (NVCR), sold 15,000 shares at $40.15 ($602K) on 2019-01-09, disclosed to the SEC on 2019-01-11.
Open-market sale of $602k NVCR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2021-03-10 | $629K | — | Filing → |
| NVCR | SELL | 2021-03-08 | $848K | — | Filing → |
| NVCR | SELL | 2021-03-04 | $716K | — | Filing → |